Karo Pharma AB Stock
Karo Pharma AB Stock
With 6 Buy predictions and not the single Sell prediction the community is currently very high on Karo Pharma AB.
With a target price of 51 € there is potential for a 837.5% increase which would mean more than doubling the current price of 5.44 € for Karo Pharma AB.
Pros and Cons of Karo Pharma AB in the next few years
Pros
?
C******** o* t** e**********
?
B****
?
G***** c******* t* c**********
Cons
?
M***** P*******
?
S********** s********
?
W********* I********* f** t** n*** y****
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Karo Pharma AB vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Karo Pharma AB | - | - | - | - | - | - | - |
| Active Biotech AB | 24.240% | -2.941% | -8.333% | -59.259% | -25.000% | -93.900% | -97.643% |
| Medivir AB | -18.050% | 21.758% | 326.154% | -22.517% | 225.882% | -85.067% | -86.995% |
| Immunic Inc. | -2.380% | 3.364% | 37.050% | -33.748% | 85.814% | -54.833% | -94.373% |
Comments
Karooooo (NASDAQ:KARO) was upgraded by analysts at Wall Street Zen from a "hold" rating to a "buy" rating.
Show more
Ratings data for KARO provided by MarketBeat
Karooooo (NASDAQ:KARO) was upgraded by analysts at UBS Group AG from a "neutral" rating to a "strong-buy" rating.
Show more
Ratings data for KARO provided by MarketBeat
Karooooo Ltd. (NASDAQ: KARO) had its "outperform" rating re-affirmed by analysts at Raymond James Financial, Inc.. They now have a $60.00 price target on the stock, up previously from $58.00.
Show more
Ratings data for KARO provided by MarketBeat